Facebook Tracking Image

National Comprehensive Cancer Network

Interactive CME


Educational Events & Programs

NCCN Policy Summit:
Defining, Measuring, and Applying Quality in an Evolving Health Policy Landscape and the Implications for Cancer Care

 

NCCN POLICY SUMMIT DATE > Thursday, September 12, 2019 > Register Now!

NCCN POLICY SUMMIT LOCATION > The National Press Club • Washington, DC

 

OVERVIEW

Register now! The NCCN will host a Policy Summit: Defining, Measuring, and Applying Quality in an Evolving Health Policy Landscape and the Implications for Cancer Care on September 12, 2019 in Washington, DC.

The summit will present diverse perspectives related to defining, measuring, and paying for quality as cancer care is inundated with innovative, personalized, and high-cost interventions. Experts in the field will discuss the role of outcomes-based oncology quality measures in policy decision-making, including how the patient experience is considered and applied in clinical decision-making. The summit will also evaluate how clinical utility and personalized medicine outcomes shape the health care system.  These discussions will culminate with how the various measures, policies, and regulations ultimately impact patient care.

Please check back often for additional updates regarding the summit. If you have any meeting content or agenda questions, please contact Lindsey Bandini, MPH, Quality of Oncology Care Fellow, U.S. and Global Development. For any media questions, please contact Rachel Darwin, Public Relations Manager.


AGENDA*

8:30 – 9:30 AM

Breakfast and Registration

9:30 – 9:35 AM

Welcome and Introductions

Wui-Jin Koh, MD
National Comprehensive Cancer Network

9:40 – 10:30 AM

Defining and Measuring Quality under Current Value-based Care Models and Implications for the Delivery of Cancer Care

Kerin Adelson, MD
Yale Cancer Center/Smilow Cancer Hospital

Diana Verrilli, MPH
McKesson Specialty Health

10:30 – 10:40 AM

Break

10:40 AM – 12:00 PM

Panel Discussion: Application and Measurement of Quality in Cancer Care Delivery Systems: Challenges & Lessons Learned

Moderated by:
Clifford Goodman, PhD
The Lewin Group

Panelists:
Kerin Adelson, MD
Yale Cancer Center/Smilow Cancer Hospital

Alan Balch, PhD
National Patient Advocate Foundation

Alexandra Chong, PhD
Center for Medicare & Medicaid Innovation (CMMI)

Nancy L. Keating, MD, MPH
Dana-Farber/Brigham and Women’s Cancer Center
Massachusetts General Hospital Cancer Center

Diana Verrilli, MPH
McKesson Specialty Health

Jacqueline Waldrop, MS
Pfizer Inc

Tracy Wong, MBA
Seattle Cancer Care Alliance

12:00 – 12:50 PM

Lunch

12:50 – 1:30 PM

The Role of Standardized Performance Measures in Ensuring Quality in Cancer Care

Shantanu Agrawal, MD, MPhil
National Quality Forum (NQF)

1:35 – 2:55 PM

Panel Discussion:
The Future of Defining, Standardizing, and Reporting Quality in Cancer Care

Moderated by:
Clifford Goodman, PhD
The Lewin Group

Panelists:
Reena Duseja, MD, MS
Centers for Medicare and Medicaid Services (CMS)

Bryan Loy, MD, MBA
Humana

Jim Martineau, MBA
Flatiron

Kashyap Patel, MD
Carolina Blood and Cancer Care

Lawrence N. Shulman, MD
Abramson Cancer Center at the University of Pennsylvania

Gaurav Singal, MD
Foundation Medicine

Ronald S. Walters, MD, MBA, MHA, MS
The University of Texas MD Anderson Cancer Center

2:55 – 3:00 PM

Wrap-up and Conclusions      

Alyssa Schatz, MSW
National Comprehensive Cancer Network

*Subject to change.


SUPPORTERS

Supported by Adaptive Biotechnologies; AmerisourceBergen; an educational donation provided by Amgen; Apobiologix; Astellas; AstraZeneca through its NCCN Corporate Council Membership; Celgene Corporation; Eisai Inc.; EMD Serono; Ferring Pharmaceuticals; Foundation Medicine, Inc.; GSK; HELSINN; Heron; Incyte Corporation; Janssen Oncology, Pharmaceutical Companies of Johnson & Johnson; Kite, a Gilead Company; an independent educational grant from Merck & Co., Inc.; Novartis Oncology; Regeneron Pharmaceuticals Inc; TESARO, A GSK Company; and Verastem Oncology. Sponsored by Boehringer Ingelheim Pharmaceuticals Inc; Bristol-Myers Squibb; Dendreon Pharmaceuticals LLC. This event is sponsored by Lilly Oncology; This activity was made possible by Pharmacyclics, an AbbVie Company.

As of September 4, 2019.


Access the Library of White Papers!

NCCN offers a broad library of white papers from previous summits that may be pertinent to your organization.

View Supporter Opportunities.

NCCN offers organizations various supporter opportunities.